ALDX

Aldeyra Therapeutics (ALDX)

About Aldeyra Therapeutics (ALDX)

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Details

Daily high

$5.12

Daily low

$4.93

Price at open

$5.02

52 Week High

$7.20

52 Week Low

$1.14

Market cap

298.4M

Dividend yield

0.00%

Volume

47,557

Avg. volume

1.7M

P/E ratio

-6.87

Aldeyra Therapeutics News